Venture Creation Studio

Portfolio Companies Built Correctly
from Day One.

Zenphia co-builds companies with equity participation from formation. Every portfolio company launches with complete execution infrastructure already in place.

Venture Creation Studio · Gene Therapy
VectorGen
Next-Generation Lentiviral Technology · HIV Functional Cure

VectorGen is pioneering A-Frame — a patented next-generation lentivector platform with CRISPR-based site-specific integration, conditional self-inactivation, and large multi-gene payload capacity.

Gene TherapyCRISPRHIV CureLentiviral Platform$22.7B Market
Venture Creation Studio · Leadership Intelligence
Apex Protocol
Leadership Intelligence & Verification Platform

Apex Protocol is a new category platform that measures, validates, and deploys leadership capability over time — providing longitudinal, outcome-linked intelligence for boards and investors.

Leadership IntelligenceBoard AdvisoryInstitutionalLife Sciences

Business Model

Five Revenue Tiers.
3–4x the Returns of Advisory-Only Models.

Tier 01
Entry Assessments
$8K – $15K

IP readiness, leadership gap, execution infrastructure audits.

Tier 02
Specialized Services
$75K – $500K

FDA regulatory pathway, clinical trial safety, IND/NDA.

Tier 03
Full Advisory
$35K – $500K

End-to-end lab-to-market programs, governance design.

Tier 04
Leadership Deployment
$80K – $175K

C-suite search with governance design. Fractional advisory.

Tier 05
Venture Creation
$50K–$100K + Equity

Performance-contingent building. 5–15% equity participation.

$600K–$1.5M
Year 1 Projection
3–4×
vs. Advisory Model
$54.5B
Market Size by 2030